APA

Arafat W. O., Gómez-Navarro J., Buchsbaum D. J., Xiang J., Wang M., Casado E., Barker S. D., Mahasreshti P. J., Haisma H. J., Barnes M. N., Siegal G. P., Alvarez R. D., Hemminki A., Nettelbeck D. M. & Curiel D. T. (20020419). Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. : Gene therapy.

Chicago

Arafat W O, Gómez-Navarro J, Buchsbaum D J, Xiang J, Wang M, Casado E, Barker S D, Mahasreshti P J, Haisma H J, Barnes M N, Siegal G P, Alvarez R D, Hemminki A, Nettelbeck D M and Curiel D T. 20020419. Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. : Gene therapy.

Harvard

Arafat W. O., Gómez-Navarro J., Buchsbaum D. J., Xiang J., Wang M., Casado E., Barker S. D., Mahasreshti P. J., Haisma H. J., Barnes M. N., Siegal G. P., Alvarez R. D., Hemminki A., Nettelbeck D. M. and Curiel D. T. (20020419). Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. : Gene therapy.

MLA

Arafat W O, Gómez-Navarro J, Buchsbaum D J, Xiang J, Wang M, Casado E, Barker S D, Mahasreshti P J, Haisma H J, Barnes M N, Siegal G P, Alvarez R D, Hemminki A, Nettelbeck D M and Curiel D T. Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. : Gene therapy. 20020419.